Lexicon Pharmaceuticals, Inc. (LXRX) Social Stream
LEXICON PHARMACEUTICALS INC (LXRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LXRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 1 | $6 | $6 | $6 | $1.16 | 417.24% |
| 2022-06-13 | 1 | $5 | $5 | $5 | $1.16 | 331.03% |
| 2022-07-01 | 2 | $20 | $5 | $12.5 | $1.16 | 977.59% |
| 2023-03-02 | 2 | $20 | $10 | $15 | $1.16 | 1193.1% |
| 2023-05-02 | 3 | $20 | $3 | $11 | $1.16 | 848.28% |
| 2023-08-03 | 4 | $10 | $3 | $7 | $1.16 | 503.45% |
| 2023-08-05 | 4 | $10 | $2.3 | $5.766 | $1.16 | 397.07% |
| 2023-09-17 | 4 | $10 | $1.65 | $5.55 | $1.16 | 378.45% |
The Trend in the Analyst Price Target
LXRX's average price target has moved down $0.45 over the prior 22 months.
LXRX reports an average of 379.91% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-02 | 2 | 20 | 10 | 15 | 2.18 | 588.07% |
| 2023-03-07 | 3 | 20 | 3 | 11 | 2.58 | 326.36% |
| 2023-05-02 | 3 | 20 | 3 | 11 | 2.38 | 362.18% |
| 2023-05-02 | 4 | 20 | 3 | 11 | 2.38 | 362.18% |
| 2023-08-03 | 4 | 10 | 3 | 7 | 1.92 | 264.58% |
LXRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 15 months, LXRX's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- LXRX has a greater upside potential (average analyst target price relative to current price) than 1322.56% of all US stocks.
- In the context of all US stocks, LEXICON PHARMACEUTICALS INC's variance in analysts' estimates is lower than -701.52% of them.
- In terms of how LEXICON PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 99.73% of that group.
- In terms of how LEXICON PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 253.22% of that group.
Stocks similar to LEXICON PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CBAY, RMTI, and RIGL.
View All Top Stocks by Price Target
Is LXRX a Buy, Hold or Sell? See the POWR Ratings now!